It says such tools could help companies screen new product ideas.
Fluxome (Easton, PA) is taking part in a project to develop software that may help quicken the development time for products such as nutraceuticals. Although the company declined to provide specific details, it says that the three-year, €2.9 million BioPreDyn project is being funded by the European Commission and its Seventh Framework Program, which supports R&D efforts in the EU.
In an interview with Nutritional Outlook, Jean-Marie Mouillon, Fluxome’s R&D director, explained that project will focus on developing analysis software for use earlier on in the development process. It says such tools could help companies screen new-product ideas and optimize the production process in a “reliable, predictive, and quantitative way.”
“We hope that by using [a] more in silico [computer-simulated] modeling approach at an early stage of product development, we will be able to improve our screening capacity for new products [and] also be able to better estimate the timeframe of the development phase of a product,” said Mouillon. However, he added, “It is too early to explain how the software [will] work…”
Fluxome says it is the only nutraceutical company participating in the project. Eight academic labs and three industrial companies, all from Europe, are participating. As for the software’s end-users, Fluxome says they may be both research institutions and private biotechnology companies like Fluxome.
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.